Company intelligence / Profile preview

Promega Corporation

Madison, Wisconsin, USApromega.com ↗
Ownership
Private
Employees
~1400
Development stage
Commercial
01

Overview

Not applicable (research tools company, not a therapeutic developer)

Modalities
Small moleculesbiologicscell and gene therapy tools
Industry
Non-Drug Biotech
02

Drug pipeline

1 asset

OncoMate MSI Dx Analysis System

Commercial
Indications
Colorectal cancer, Lynch syndrome
03

Partnerships

EditCo Bio (announced April 2025)

Beyond the preview

Go deeper on Promega Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Promega Corporation.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call